• Something wrong with this record ?

MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer

AM. Cossu, F. Melisi, TMR. Noviello, LS. Pasquale, P. Grisolia, C. Reale, M. Bocchetti, M. Falco, C. Tammaro, N. Accardo, F. Longo, S. Allosso, M. Mesolella, R. Addeo, F. Perri, A. Ottaiano, F. Ricciardiello, E. Amler, C. Ambrosino, G. Misso, M....

. 2024 ; 35 (1) : 102140. [pub] 20240206

Status not-indexed Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24005611

MicroRNAs (miRNAs) are involved in post-transcriptional gene expression regulation and in mechanisms of cancer growth and metastases. In this light, miRNAs could be promising therapeutic targets and biomarkers in clinical practice. Therefore, we investigated if specific miRNAs and their target genes contribute to laryngeal squamous cell carcinoma (LSCC) development. We found a significant decrease of miR-449a in LSCC patients with nodal metastases (63.3%) compared with patients without nodal involvement (44%). The AmpliSeq Transcriptome of HNO-210 miR-449a-transfected cell lines allowed the identification of IL6-R as a potential target. Moreover, the downregulation of IL6-R and the phosphorylation reduction of the downstream signaling effectors, suggested the inhibition of the IL-6 trans-signaling pathway. These biochemical effects were paralleled by a significant inhibition of invasion and migration in vitro and in vivo, supporting an involvement of epithelial-mesenchymal transition. These findings indicate that miR-449a contributes to suppress the metastasization of LSCC by the IL-6 trans-signaling block and affects sensitivity to external stimuli that mimic pro-inflammatory conditions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24005611
003      
CZ-PrNML
005      
20240412130937.0
007      
ta
008      
240405s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.omtn.2024.102140 $2 doi
035    __
$a (PubMed)38425711
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Cossu, Alessia Maria $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
245    10
$a MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer / $c AM. Cossu, F. Melisi, TMR. Noviello, LS. Pasquale, P. Grisolia, C. Reale, M. Bocchetti, M. Falco, C. Tammaro, N. Accardo, F. Longo, S. Allosso, M. Mesolella, R. Addeo, F. Perri, A. Ottaiano, F. Ricciardiello, E. Amler, C. Ambrosino, G. Misso, M. Ceccarelli, M. Caraglia, M. Scrima
520    9_
$a MicroRNAs (miRNAs) are involved in post-transcriptional gene expression regulation and in mechanisms of cancer growth and metastases. In this light, miRNAs could be promising therapeutic targets and biomarkers in clinical practice. Therefore, we investigated if specific miRNAs and their target genes contribute to laryngeal squamous cell carcinoma (LSCC) development. We found a significant decrease of miR-449a in LSCC patients with nodal metastases (63.3%) compared with patients without nodal involvement (44%). The AmpliSeq Transcriptome of HNO-210 miR-449a-transfected cell lines allowed the identification of IL6-R as a potential target. Moreover, the downregulation of IL6-R and the phosphorylation reduction of the downstream signaling effectors, suggested the inhibition of the IL-6 trans-signaling pathway. These biochemical effects were paralleled by a significant inhibition of invasion and migration in vitro and in vivo, supporting an involvement of epithelial-mesenchymal transition. These findings indicate that miR-449a contributes to suppress the metastasization of LSCC by the IL-6 trans-signaling block and affects sensitivity to external stimuli that mimic pro-inflammatory conditions.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Melisi, Federica $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Noviello, Teresa Maria Rosaria $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy $u Department of Electrical Engineering and Information Technology, University of Naples "Federico II", Napoli, Italy
700    1_
$a Pasquale, Lucia Stefania $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Grisolia, Piera $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Reale, Carla $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Bocchetti, Marco $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Falco, Michela $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Tammaro, Chiara $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Accardo, Nunzio $u Ear, Nose, and Throat Unit, AORN "Antonio Cardarelli", Naples, Italy
700    1_
$a Longo, Francesco $u Head and Neck Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione G. Pascale", IRCCS, Naples, Italy
700    1_
$a Allosso, Salvatore $u Department of Neurosciences, Reproductive and Odontostomatological Sciences, UOC Federico II, 80121 Naples, Italy
700    1_
$a Mesolella, Massimo $u Department of Neurosciences, Reproductive and Odontostomatological Sciences, UOC Federico II, 80121 Naples, Italy
700    1_
$a Addeo, Raffaele $u Medical Oncology Unit, San Giovanni di Dio Hospital, 80027 Frattamaggiore, Italy
700    1_
$a Perri, Francesco $u Head and Neck Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione G. Pascale", IRCCS, Naples, Italy
700    1_
$a Ottaiano, Alessandro $u SSD Innovative Therapies for Abdominal Metastases, Abdominal Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione G. Pascale", IRCCS, Naples, Italy
700    1_
$a Ricciardiello, Filippo $u Ear, Nose, and Throat Unit, AORN "Antonio Cardarelli", Naples, Italy
700    1_
$a Amler, Evzen $u UCEEB, Czech Technical University, Třinecká 1024, 273 43 Buštěhrad, Czech
700    1_
$a Ambrosino, Concetta $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy $u Department of Science and Technology, University of Sannio, 82100 Benevento, Italy
700    1_
$a Misso, Gabriella $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy
700    1_
$a Ceccarelli, Michele $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy $u Department of Electrical Engineering and Information Technology, University of Naples "Federico II", Napoli, Italy
700    1_
$a Caraglia, Michele $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
700    1_
$a Scrima, Marianna $u Biogem Scarl, Institute of Genetic Research, 83031 Ariano Irpino, Italy
773    0_
$w MED00189560 $t Molecular therapy. Nucleic acids $x 2162-2531 $g Roč. 35, č. 1 (2024), s. 102140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38425711 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240405 $b ABA008
991    __
$a 20240412130929 $b ABA008
999    __
$a ok $b bmc $g 2075972 $s 1215373
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 35 $c 1 $d 102140 $e 20240206 $i 2162-2531 $m Molecular therapy. Nucleic acids $n Mol Ther Nucleic Acids $x MED00189560
LZP    __
$a Pubmed-20240405

Find record

Citation metrics

Archiving options